CJC-1295

CND2 is a sterile aqueous formulation containing CJC‑1295 (without Drug Affinity Complex) at 2 mg per 10 mL vial, supplied as a pack of 10 vials. The product is intended for preclinical and in vitro research into somatotropic‑axis signalling, GHRH receptor pharmacology, pituitary GH release, IGF‑1 pathway modulation, and downstream cellular signalling. Typical applications include receptor binding and functional assays, cell‑culture experiments, and mechanistic pharmacology studies. Exact formulation vehicle, excipients, pH, preservative status, sterility/endotoxin results, and stability/expiry are batch‑specific and provided on the Certificate of Analysis.Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. Use is restricted to in vitro testing and laboratory experimentation by qualified personnel. Bodily introduction into humans or animals is strictly forbidden. This product is not a drug, food, or cosmetic and must not be misbranded, misused, or administered.